Programs

HomePrograms ▶ Unrestricted Grants
Unrestricted Grants

The letter of intent deadline for unrestricted grants has passed. The information below is for reference only.  Investigators who have been invited to submit full applications can access the submission form through the log-in portal here.

  • All grants are targeted towards early-stage investigators, unless stated otherwise. 
  • You will be required to take an eligibility quiz to gain access to the letter of intent.
  • Questions? Review the FAQs.
  • If your question is not answered there, contact the ATS Research Program.

 

 

 Timeline

Grant Portfolio Opens July 17, 2024
Letters of Intent Due September 16, 2024, 11:59 PM ET 
Invitations to Applicants Late October 2024
Full Applications Due December 16, 2024, 11:59 PM ET
Award Notification March 2025
Grant Start Date July 2025

 

Unrestricted Research Grants

Five grants available
$40,000 for one year

Target audience: Early-stage investigators interested in basic science, translational, or clinical research in pulmonary, critical care, and sleep medicine

Unrestricted grants support early-stage investigators conducting research that advances the knowledge and understanding of pulmonary, critical care, and sleep medicine. A primary goal of the ATS Research Program is to enable early-stage investigators to transition to independent research careers.

The Research Program encourages applications in basic, patient-oriented, and public health topics. In the area of public health, the Research Program is particularly interested in funding projects that will inform health policy decisions. These include projects that explore the quality and safety of a specific treatment and compare the effectiveness of different therapies. 

The ATS Research Program will award up to five unrestricted research grants for $40,000 for one year for salaries, supplies, or a combination of these two. Indirect costs will not be paid to the sponsoring institution. 

The Research Program will award one grant to the top scores in each of the three society pillars: pulmonary, critical care, and sleep.* The remaining grants will be awarded to the top scores regardless of the category of submission. 

Award-specific eligibility:
• Early-stage investigators (as defined here)
• Must meet eligibility requirements for all grants found here


*While it is intended that there be one award in each pillar (pulmonary, critical care, and sleep medicine), the ATS Scientific Grant Review Committee (SGRC) reserves the right to alter this distribution dependent upon the significant scientific merit of applications.

Learn more about the grant review process here.

 

 

The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders. Founded in 1905 to combat TB, the ATS has grown to tackle asthma, COPD, lung cancer, sepsis, acute respiratory distress, and sleep apnea, among other diseases.

X Facebook LinkedIn Instagram YouTube Social Media Page

AMERICAN THORACIC SOCIETY
25 Broadway
New York, NY 10004
United States of America

Phone: +1 (212) 315-8600
Fax: +1 (212) 315-6498
Email: atsinfo@thoracic.org

© 1998 - American Thoracic Society, all rights reserved.